Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) miceMARTIN, Keith R; TREMPUS, Carol; SAULNIER, Muriel et al.Carcinogenesis (New York. Print). 2001, Vol 22, Num 9, pp 1373-1378, issn 0143-3334Article

Gender Differences in Chemical Carcinogenesis in National Toxicology Program 2-Year BioassaysKADEKAR, Sandeep; PEDDADA, Shyamal; SILINS, Ilona et al.Toxicologic pathology. 2012, Vol 40, Num 8, pp 1160-1168, issn 0192-6233, 9 p.Article

Notchi is a frequent mutational target in chemically induced lymphoma in mouseKARLSSON, Anneli; UNGERBÄCK, Jonas; RASMUSSEN, Anna et al.International journal of cancer. 2008, Vol 123, Num 11, pp 2720-2724, issn 0020-7136, 5 p.Article

Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthaleinHULLA, Janis E; FRENCH, John E; DUNNICK, June K et al.Toxicological sciences (Print). 2001, Vol 60, Num 2, pp 264-270, issn 1096-6080Article

Absence of proinflammatory cytokine gene expression in nasal biopsies from wood surface-coating industry workersGRANSTRAND, Per; NYLANDER-FRENCH, Leena A; LACKS, Greg et al.Acta oto-laryngologica. 2001, Vol 121, Num 6, pp 743-749, issn 0001-6489Article

p53^+/- Hemizygous knockout mouse: Overview of available dataSTORER, Richard D; FRENCH, John E; HASEMAN, Joseph et al.Toxicologic pathology. 2001, Vol 29, pp 30-50, issn 0192-6233, SUP-DEFECTUEUXArticle

Aflatoxin B1 and/or Hepatitis B Virus Induced Tumor Spectrum in a Genetically Engineered Hepatitis B Virus Expression and Trp53 Haploinsufficient Mouse Model System for HepatocarcinogenesisCULLEN, John M; BROWN, Danielle L; KISSLING, Grace E et al.Toxicologic pathology. 2009, Vol 37, Num 3, pp 333-342, issn 0192-6233, 10 p.Article

Exposure of Tg.AC transgenic mice to benzene suppresses hematopoietic progenitor cells and alters gene expression in critical signaling pathwaysNWOSU, Veronica C; KISSLING, Grace E; TREMPUS, Carol S et al.Toxicology and applied pharmacology. 2004, Vol 196, Num 1, pp 37-46, issn 0041-008X, 10 p.Article

Is p53 haploinsufficient for tumor suppression? Implications for the p53^+/- mouse model in carcinogenicity testingVENKATACHALAM, Sundaresan; TYNER, Stuart D; PICKERING, Curtis R et al.Toxicologic pathology. 2001, Vol 29, pp 147-154, issn 0192-6233, SUP-DEFECTUEUXArticle

N-acetyl-l-cysteine simultaneously increases mitogenesis and suppresses apoptosis in mitogen-stimulated b-lymphocytes from p53 haploinsufficient Tg.AC (v-Ha-ras) miceMARTIN, Keith R; KARI, Frank W; BARRETT, J. Carl et al.In vitro & molecular toxicology. 2000, Vol 13, Num 4, pp 237-247, issn 1097-9336Article

The use of genetically modified mice in cancer risk assessment: Challenges and limitationsEASTMOND, David A; VULIMIRI, Suryanarayana V; FRENCH, John E et al.Critical reviews in toxicology. 2013, Vol 43, Num 8, pp 611-631, issn 1040-8444, 21 p.Article

Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progressionMARTIN, Keith R; SAULNIER, Muriel J; KARI, Frank W et al.Nutrition and cancer. 2002, Vol 43, Num 1, pp 59-66, issn 0163-5581, 8 p.Article

Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient miceHULLA, Janis E; FRENCH, John E; DUNNICK, June K et al.Carcinogenesis (New York. Print). 2001, Vol 22, Num 1, pp 89-98, issn 0143-3334Article

Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53+/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalationHEALY, Laura N; PLUTA, Linda J; JAMES, R. Arden et al.Mutagenesis. 2001, Vol 16, Num 2, pp 163-168, issn 0267-8357Article

New models for assessing carcinogenesis : An ongoing processSILLS, Robert C; FRENCH, John E; CUNNINGHAM, Michael L et al.Toxicology letters. 2001, Vol 120, Num 1-3, pp 187-198, issn 0378-4274Conference Paper

Toxicology and Carcinogenesis Study of Senna in C3B6.129F1-Trp53^tm1Brd N12 Haploinsufficient MiceSURH, Inok; BRIX, Amy; FRENCH, John E et al.Toxicologic pathology. 2013, Vol 41, Num 5, pp 770-778, issn 0192-6233, 9 p.Article

RAP80 Is Critical in Maintaining Genomic Stability and Suppressing Tumor DevelopmentZHENGYU YIN; MENENDEZ, Daniel; RESNICK, Michael A et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 19, pp 5080-5090, issn 0008-5472, 11 p.Article

Single-Nucleotide Polymorphisms Associated with Skin Naphthyl-Keratin Adduct Levels in Workers Exposed to NaphthaleneRONG JIANG; FRENCH, John E; STOBER, Vandy P et al.Environmental health perspectives. 2012, Vol 120, Num 6, pp 857-864, issn 0091-6765, 8 p.Article

Panel Discussion: Alternative Mouse Models for Carcinogenicity AssessmentFRENCH, John E; LEBLANC, Bernard; LONG, Gerald G et al.Toxicologic pathology. 2010, Vol 38, Num 1, pp 72-75, issn 0192-6233, 4 p.Article

p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzeneBOLEY, Scott E; WONG, Victoria A; FRENCH, John E et al.Toxicological sciences (Print). 2002, Vol 66, Num 2, pp 209-215, issn 1096-6080Article

Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen- and tissue-dependentFRENCH, John E; LACKS, Gregory D; TREMPUS, Carol et al.Carcinogenesis (New York. Print). 2001, Vol 22, Num 1, pp 99-106, issn 0143-3334Article